Vanguard Group Inc Tenaya Therapeutics, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,862,916 shares of TNYA stock, worth $8.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,862,916

Previous 2,459,444 16.41%

Holding current value

$8.88 Million

Previous $7.97 Million 87.91%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.88 - $6.8 $1.16 Million - $2.74 Million	403,472 Added 16.41%	2,862,916 $15 Million
Q4 2023 Feb 14, 2024	BUY	$1.73 - $3.39 $504,426 - $988,442	291,576 Added 13.45%	2,459,444 $7.97 Million
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.65 $429,646 - $951,962	168,489 Added 8.43%	2,167,868 $5.53 Million
Q2 2023 Aug 14, 2023	BUY	$2.64 - $7.64 $347,825 - $1.01 Million	131,752 Added 7.05%	1,999,379 $11.7 Million
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $482,709 - $902,565	251,411 Added 15.56%	1,867,627 $5.32 Million

Q4 2022 Feb 10, 2023	BUY	$1.68 - $3.19 $933,493 - $1.77 Million	555,651 Added 52.39%	1,616,216 $3.25 Million
Q3 2022 Nov 14, 2022	SELL	$2.9 - $5.88 $8,615 - $17,469	-2,971 Reduced 0.28%	1,060,565 $3.08 Million
Q2 2022 Aug 12, 2022	SELL	$5.01 - $14.12 $110,856 - $312,433	-22,127 Reduced 2.04%	1,063,536 $5.99 Million
Q1 2022 May 13, 2022	BUY	$9.41 - $19.3 $4.98 Million - $10.2 Million	528,845 Added 94.98%	1,085,663 $12.8 Million
Q4 2021 Feb 14, 2022	BUY	$18.41 - $29.58 $991,010 - $1.59 Million	53,830 Added 10.7%	556,818 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$15.35 - $26.66 $7.72 Million - $13.4 Million	502,988 New	502,988 $10.4 Million

Others Institutions Holding TNYA

# of Institutions

Shares Held

47.2M

Call Options Held

35.8K

Put Options Held

1.1K

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $128M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Tenaya Therapeutics, Inc. Transaction History